TPMT and NUDT15 pharmacogenetic testing is now commissioned on the NHS for both adult and paediatric patients with Acute Lymphoblastic Leukaemia only, the updated national genomic test directory can be…
Dear All, The consent form project team is pleased to announce that the colorectal SACT consent forms have been reviewed and updated. They are available on the CRUK website at:…
Please click here to see version 3.0 of the Standards for the safer use of ePMA systems for use in SACT Services. We would like to thank everyone involved in all…
For information – please click here to see the final version of the National SACT Protocols: Options Appraisal. https://www.ukchemotherapyboard.org/publications The UK Chemotherapy Board will discuss the next steps at our next meeting. Kind regards,…
Please click here to see the BOPA recommendations for the use of Tall Man lettering for SACT within the UK. Also available here: https://www.bopa.org.uk/resources/bopa-recommendations-of-the-use-of-tall-man-lettering-for-systemic-anti-cancer-treatments-sact-in-the-united-kingdom-v1-0/ Kind regards, The BOPA Executive Committee
Document explaining corporate membership information with answers to FAQ’s. Available here
The Cancer Pharmacy Education & Training Standards programme has been developed to ensure that there is a baseline standard for training for all pharmacy staff within the UK who verify…
The UK BMT Pharmacists’ Group has recently updated its training passport that is designed to support pharmacists working in the area of adult haematopoietic stem cell transplantation (HSCT). It is…
Please find here the Clinician FAQs and guidance on COVID-19 vaccine for patients receiving SACT. https://www.ukchemotherapyboard.org/publications
During the COVID-19 pandemic, oncology pharmacy services have had to adapt quickly and innovatively to continue to provide care to cancer patients. This document outlines both the clinical and operational…
Please see new guidance from the UK Chemotherapy Board on ‘Personalised Medicine Approach For Fluoropyrimidine-based Therapies’. Objective of document: To provide clinical staff with guidance as to which patients should…
BOPA have produced a practical information sheet for pharmacists supporting cancer patients in the community setting. Please share this information with your community colleagues, and encourage them to sign up…
